Aceso Life Science Group (HKSE:00474) Long-Term Debt: HK$1,144.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00474 Aceso Life Science Group Ltd HKSE:00474
19 GF Score
Price HK$0.15
GF Value HK$0.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aceso Life Science Group Long-Term Debt?

Aceso Life Science Group HKSE:00474 +0.66% 19 Long-Term Debt is HK$1,144.00 Mil as of Mar. 2026. GuruFocus rates HKSE:00474 with a GF Score™ of 19/100 and a GF Value™ of HK$0.03 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Aceso Life Science Group's Long-Term Debt for the quarter that ended in Mar. 2026 was HK$1,144.00 Mil.

Aceso Life Science Group's quarterly Long-Term Debt increased from Mar. 2025 (HK$561.00 Mil) to Sep. 2025 (HK$1,097.00 Mil) and increased from Sep. 2025 (HK$1,097.00 Mil) to Mar. 2026 (HK$1,144.00 Mil).

Aceso Life Science Group's annual Long-Term Debt declined from Mar. 2024 (HK$666.00 Mil) to Mar. 2025 (HK$561.00 Mil) but then increased from Mar. 2025 (HK$561.00 Mil) to Mar. 2026 (HK$1,144.00 Mil).

Aceso Life Science Group  (HKSE:00474) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Aceso Life Science Group Long-Term Debt Related Terms

Aceso Life Science Group Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Aceso Life Science Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aceso Life Science Group Long-Term Debt Chart

Aceso Life Science Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 857.00 756.00 666.00 561.00 1,144.00

Aceso Life Science Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 666.00 17.00 561.00 1,097.00 1,144.00
HKSE:00474
19GF Score
Aceso Life Science Group Ltd HKSE:00474
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of HK$1,144.00 Mil mean?
Aceso Life Science Group (HKSE:00474) has a Long-Term Debt of HK$1,144.00 Mil as of Mar. 2026.
Is Aceso Life Science Group's Long-Term Debt too high?
Aceso Life Science Group's current Long-Term Debt is HK$1,144.00 Mil. Overall, Aceso Life Science Group has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aceso Life Science Group's Long-Term Debt compare to URI and SUNB?
Aceso Life Science Group's Long-Term Debt of HK$1,144.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Business Services company?
A good Long-Term Debt depends on the Business Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Aceso Life Science Group's current Long-Term Debt is HK$1,144.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aceso Life Science Group stock overvalued right now?
Based on GuruFocus' analysis, Aceso Life Science Group (HKSE:00474) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.03, compared to a current price of HK$0.15 — trading 406.7% above its estimated fair value. The current Long-Term Debt is HK$1,144.00 Mil. Aceso Life Science Group's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Aceso Life Science Group (HKSE:00474), the current Long-Term Debt is HK$1,144.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?

Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued. The current stock price of HK$0.15 is trading 406.7% above its estimated GF Value™ of HK$0.03. GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.

Key valuation signals for HKSE:00474:

  • Long-Term Debt: HK$1,144.00 Mil
  • GF Value™: HK$0.03 vs. price of HK$0.15 (406.7% above fair value)
  • GF Score™: 19/100 with 6 warning signs

No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aceso Life Science Group Business Description

Address 6 - 8 Harbour Road, Rooms 2501 - 2509, 25th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score

Get the complete analysis for HKSE:00474

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.15
Price
HK$0.03
GF Value